KALA

Kala Pharmaceuticals Inc, headquartered in Watertown, Massachusetts, is a pioneering biopharmaceutical company dedicated to the discovery, development, and commercialization of advanced therapies for ocular conditions. Utilizing its proprietary nanoparticle-based mucus penetrating particle (MPP) technology, Kala enhances drug delivery and therapeutic outcomes in ophthalmic treatment. With a clear focus on addressing significant unmet medical needs in eye care, the company is well-positioned to lead innovation in the ophthalmology market, underscoring its commitment to transforming patient outcomes.